NouvSoma001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NouvSoma001, covering 2026-01-21 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders [Phase 1]